Position in DNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,499,937
+$1,333,392 QoQ
Shares Held
151,356
+457.1% QoQ
Ownership
0.225%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 183 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Derivatives in DNA
reported options exposure · as of Dec 31, 2025CallValue
$1,851,468
CallShares
222,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. DNA ranks #142 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in DNA
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,499,937 | 151,356 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $166,545 | 27,169 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,851,468 | 222,800 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $280,644 | 33,772 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,386,746 | 163,700 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $672,423 | 59,771 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $5,365,824 | 546,418 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $545,010 | 55,500 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $493,075 | 60,500 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $7,112,105 | 872,651 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $598,210 | 73,400 | Put | Defined | 2024-11-14 | |
| 2024-06-30 DNABW | — | 71,236 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $5,797,027 | 17,356,369 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 DNABW | — | 71,236 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $98,778 | 85,154 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 DNABW | — | 71,236 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $676,626 | 400,371 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 DNABW | — | 71,236 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $19,506 | 10,777 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 DNABW | — | 71,236 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 DNABW | — | 71,236 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $14,370 | 10,805 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 DNABW | — | 71,236 | Shares | Defined | 2023-02-14 | |
| 2022-12-31 | $44,624 | 26,405 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 DNABW | — | 71,236 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 DNABW | — | 71,236 | Shares | Defined | 2022-08-15 | |
| 2022-06-30 | $27,108 | 11,390 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 DNABW | — | 71,236 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $8,913,392 | 2,211,760 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 DNABW | — | 71,236 | Shares | Defined | 2022-02-14 | |
| 2021-12-31 | $2,379,020 | 286,284 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 DNABW | — | 157,511 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $10,363,638 | 894,188 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||